Terry has a solid track record of leadership in the life sciences with over 25 years of experience in growing innovative technology companies and building value for customers, shareholders, and employees. Previously, he was co-founder and Executive Vice President of Cellomics, a leading provider of automated cellular analysis instruments, assays, and informatics software that was acquired by Fisher Scientific (now part of Thermo Fisher). At Cellomics, he invented and commercialized the company’s industry leading high content screening products. Prior to Cellomics, Terry was founder and CEO of Biological Detection, Inc. a bio-imaging software company and earlier was Vice President of Biological Detection Systems, Inc. a bio-imaging systems, software, and reagents company that was acquired by Amersham (now part of GE Healthcare). Former affiliations include Cytyc Corporation, Lockheed Martin, and PPG Industries. Terry has a BS and MS in Electrical Engineering and holds numerous patents in the area of cell-based screening instrumentation and informatics.